Carotid artery plaque examinations performed with serial ultrasound scans could help identify patients at high risk for a heart attack or other potentially lethal cardiovascular conditions.
Dr. Markus Reiter, at the Medical University of Vienna, evaluated 1268 asymptomatic patients at high risk of cardiovascular disease using computer-assisted gray-scale median (GSM) ultrasound carotid measurements. Plaque volume identified carotid disease in 574 patients who had a second ultrasound exam six to nine months later to measure plaque changes. Nearly half of those patients had lower GSM levels, and 37% experienced a major adverse cardiovascular event, such as a heart attack, a stroke, or cardiac surgery, within three years of the second ultrasound. Vulnerable carotid plaque indicated not only increased risk of stroke but also disease progression elsewhere in the cardiovascular system.
Study results appeared in the September issue of Radiology.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.